Sonoma Pharmaceuticals Ownership | Who Owns Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals Ownership Summary

Sonoma Pharmaceuticals is owned by 3.62% institutional investors, 1.19% insiders, and 95.20% retail investors. Vanguard group is the largest institutional shareholder, holding 1.27% of SNOA shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.14% of its assets in Sonoma Pharmaceuticals shares.

SNOA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Sonoma Pharmaceuticals	3.62%	1.19%	95.20%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Specialty & Generic Drug Manufacturers Stocks	26.16%	11.89%	61.94%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	20.87K	1.27%	$80.99K
Citadel advisors	195.16K	1.25%	$41.41K
Geode capital management	17.62K	1.07%	$68.35K
Drw securities	17.07K	1.04%	$66.23K
State street	24.32K	0.16%	$5.16K
Tower research capital llc (trc)	1.54K	0.09%	$5.96K
Citigroup	656.00	0.04%	$2.54K
Rockefeller capital management	646.00	0.04%	$2.51K
Global retirement partners	438.00	0.03%	$1.70K
Blackrock	2.27K	0.01%	$481.00

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Drw securities	17.07K	0.00%	$66.23K
Tower research capital llc (trc)	1.54K	0.00%	$5.96K
Heron bay capital management	-	-	-
Blackrock	2.27K	-	$481.00
Renaissance	-	-	-
Rockefeller capital management	646.00	-	$2.51K
Two sigma securities	-	-	-
Susquehanna group, llp	-	-	-
Advisor group	-	-	-
Geode capital management	17.62K	-	$68.35K

Top Buyers

Holder	Shares	% Assets	Change
Citadel advisors	195.16K	-	195.16K
Vanguard group	20.87K	-	20.87K
Drw securities	17.07K	0.00%	17.07K
Citigroup	656.00	-	656.00
Rockefeller capital management	646.00	-	646.00

Top Sellers

Holder	Shares	% Assets	Change
Susquehanna group, llp	-	-	-46.05K
Jane street group	-	-	-45.30K
Heron bay capital management	-	-	-33.78K
Xtx topco	-	-	-19.83K
Renaissance	-	-	-17.80K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard group	20.87K	-	20.87K	$80.99K
Drw securities	17.07K	0.00%	17.07K	$66.23K
Rockefeller capital management	646.00	-	646.00	$2.51K
Global retirement partners	438.00	-	438.00	$1.70K
Mai capital management	124.00	-	124.00	$482.00

Sold Out

Holder	Change
Advisor group	-200.00
Qube research	-3.40K
Hrt financial lp	-11.84K
Millennium management	-13.02K
Two sigma securities	-15.32K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	18	63.64%	59,357	-30.08%	3	13.52%	12	140.00%	1	-50.00%
Jun 30, 2025	12	-	84,901	156.84%	5	101.48%	5	-	2	-
Mar 31, 2025	12	33.33%	33,056	63.98%	2	119.08%	5	150.00%	2	100.00%
Dec 31, 2024	9	-25.00%	20,159	-27.39%	1	19.10%	2	-60.00%	1	-85.71%
Sep 30, 2024	12	-29.41%	27,765	-93.62%	2	41.15%	5	-50.00%	7	250.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Institutional Extnd Mkt Idx Tr	18.79K	1.14%	12.12K
Fidelity Extended Market Index	8.88K	0.54%	-62.00
Spartan Extended Market Index Pool F	3.09K	0.19%	62.00
Spartan Extended Market Index Pool E	2.97K	0.18%	2.92K
Fidelity Total Market Index	2.53K	0.15%	-
Fidelity Series Total Market Index	2.31K	0.14%	-
Spartan Total Market Index Pool G	812.00	0.05%	-
Fidelity Nasdaq Composite Index	248.00	0.02%	-
Northern Trust Extended Eq Market Idx	96.00	0.01%	-
NT Ext Equity Mkt Idx Fd - L	96.00	0.01%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 12, 2018	Miller Robert E	Chief Financial Officer	Buy	$4.84K
Mar 13, 2018	Miller Robert E	Chief Financial Officer	Buy	$4.92K
Mar 12, 2018	Miller Robert E	Chief Financial Officer	Buy	$4.84K
Mar 09, 2018	Miller Robert E	Chief Financial Officer	Buy	$4.68K
Mar 08, 2018	Schutz James J	Chief Executive Officer	Buy	$9.87K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q2	-	-
2023 Q4	-	-
2023 Q3	-	-

SNOA Ownership FAQ

Who Owns Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals shareholders are primarily institutional investors at 3.62%, followed by 1.19% insiders and 95.19% retail investors. The average institutional ownership in Sonoma Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.16%, which Sonoma Pharmaceuticals falls below.

Who owns the most shares of Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals’s largest shareholders are Vanguard group (20.87K shares, 1.27%), Citadel advisors (195.16K shares, 1.25%), and Geode capital management (17.62K shares, 1.07%). Together, they hold 3.60% of Sonoma Pharmaceuticals’s total shares outstanding.

Does Blackrock own Sonoma Pharmaceuticals?

Yes, BlackRock owns 0.01% of Sonoma Pharmaceuticals, totaling 2.27K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 481$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Sonoma Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Drw securities is Sonoma Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 17.07K Sonoma Pharmaceuticals shares, valued at 66.23K$.

Who is the top mutual fund holder of Sonoma Pharmaceuticals shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Sonoma Pharmaceuticals shares, with 1.14% of its total shares outstanding invested in 18.79K Sonoma Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools